Menu
GWAS Study

Genome-wide association study of REM sleep behavior disorder in Parkinson's disease.

Sosero YL, Heilbron K, Fontanillas P et al.

40998812 PubMed ID
GWAS Study Type
18423 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SY
Sosero YL
HK
Heilbron K
FP
Fontanillas P
NL
Norcliffe-Kaufmann L
YE
Yu E
RU
Rudakou U
RJ
Ruskey JA
FK
Freeman K
AF
Asayesh F
BK
Brolin KA
SM
Swanberg M
MH
Morris HR
WL
Wu L
RR
Real R
PL
Pihlstrøm L
TM
Tan M
GT
Gasser T
BK
Brockmann K
LH
Liu H
HM
Hu MTM
GD
Grosset DG
LS
Lewis SJG
KJ
Kwok JB
PP
Pastor P
AI
Alvarez I
SM
Skorvanek M
LA
Lackova A
OM
Ostrozovicova M
RM
Rizig M
KL
Krohn L
GZ
Gan-Or Z
Chapter II

Abstract

Summary of the research findings

REM sleep behavior disorder (RBD), is a prodromal synucleinopathy affecting a subset of Parkinson's disease (PD) patients and associated with neuropsychiatric symptoms. This study compared the genetic profiles of 13,020 PD patients with probable RBD (PD + RBD) and 5403 without (PD-RBD) using genome-wide association study (GWAS). RBD was assessed by questionnaires or self-reporting. Potential genetic correlations between neuropsychiatric traits and PD + RBD were assessed using linkage disequilibrium score regression. The top variant in the SNCA locus was associated with PD + RBD (rs10005233-T, OR = 1.21, 95% CI = 1.16-1.27, p = 1.81e-15). PD risk variants in SNCA (rs5019538-G, OR = 0.85, 95% CI = 0.81-0.89, p = 2.46e-10; rs356182-G, OR = 0.89, 95% CI = 0.84-0.95, p = 0.0001) and LRRK2 loci (rs34637584, OR = 0.41, 95% CI = 0.28-0.61, p = 1.04e-5) were associated with reduced PD + RBD risk. A suggestive genetic correlation between attention deficit hyperactivity disorder and PD + RBD was observed but was not statistically significant after correction. These findings highlight genetic distinctions between PD + RBD and PD-RBD, offering insights into PD stratification and potential subtype-specific treatments.

5,403 cases, 13,020 controls

Chapter III

Study Statistics

Key metrics and study information

18423
Total Participants
GWAS
Study Type
No
Replicated
Canada, Sweden, U.S., Norway, U.K., Slovakia, Australia, Germany, Spain
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.